Info Sheet

IBC Review and Consulting Services

September 30, 2019

No more waiting for a standing meeting. No submission deadlines. Responsive and flexible—only 10 business days or less from submission to institutional biosafety committee (IBC) review.


Preparing for Multisite Gene Therapy Studies

The fast and dramatic growth in the field of gene therapy is unprecedented, as the US FDA and regulatory agencies of several other countries have begun issuing approvals for licensed…

Info Sheet

IBC-Ready™ Support

December 13, 2018

With IBC-Ready™, Advarra can help reduce confusion and administrative burden by coordinating with the sponsor, site personnel and local IBC(s) to complete local IBC submission forms.


An Introduction to Human Gene Transfer Research and Institutional Biosafety Committees (IBCs)

July 19, 2018

Advarra’s Director of Biosafety Services Daniel Eisenman discusses the basics of research involving genetic engineering and the role played by the IBC in conducting safe and responsible research.

Info Sheet

Advarra Services Overview

April 25, 2018

Advarra's integrated research compliance solutions help make your research altogether better.

Info Sheet

IBC Services Overview

April 25, 2018

Advarra's IBC services provide comprehensive review and support capabilities for clinical, non-clinical and pre-clinical research involving genetic engineering.


IRB-Connect Video

August 4, 2017

IRB-Connect allows seamless access for your data from Advarra's Center for IRB Intelligence (CIRBI) Platform to your eTMF.